FdaApplication

ANDA 204285

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2016-08-04

Products (2)

ProductActive ingredientStrengthDosage form
IMATINIB MESYLATEIMATINIB MESYLATEEQ 100MG BASETABLET;ORAL
IMATINIB MESYLATEIMATINIB MESYLATEEQ 400MG BASETABLET;ORAL

2 products